E
Clover Health Investments, Corp. CLOV
$1.09 $0.065.83%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 2/21/2024Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D- on 2/21/2024 due to a decline in the volatility index.
D
Sell 2/6/2024Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D- from E+ on 2/6/2024 due to an increase in the volatility index.
E
Sell 1/22/2024Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D- on 1/22/2024 due to a decline in the valuation index.
D
Sell 1/5/2024Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D- from E+ on 1/5/2024 due to an increase in the total return index and valuation index.
E
Sell 12/20/2023Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D- on 12/20/2023 due to a large decline in the growth index, total return index and volatility index. Operating cash flow declined 135.32% from $53.17M to -$18.78M, EBIT declined 66.92% from -$24.06M to -$40.16M, and earnings per share declined from -$0.0601 to -$0.0863.
D
Sell 8/25/2023Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D- from E+ on 8/25/2023 due to an increase in the growth index, total return index and solvency index. EBIT increased 66.87% from -$72.61M to -$24.06M, and earnings per share increased from -$0.1516 to -$0.0601.
E
Sell 3/14/2023Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D on 3/14/2023 due to a noticeable decline in the growth index, solvency index and volatility index. Operating cash flow declined 305.96% from $101.66M to -$209.37M, EBIT declined 44.38% from -$74.9M to -$108.13M, and earnings per share declined from -$0.1577 to -$0.1759.
D
Sell 2/9/2023Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index.
E
Sell 2/8/2023Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell 5/16/2022Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell 5/13/2022Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D on 05/13/2022.
D
Sell 5/11/2022Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D from D- on 5/11/2022 due to a noticeable increase in the growth index and total return index. Total revenue increased 147.1% from $370.07M to $914.43M, earnings per share increased from -$0.4453 to -$0.1592, and EBIT increased 59.9% from -$186.79M to -$74.91M.
D
Sell 5/5/2022Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
E
Sell 4/20/2022Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D- on 4/20/2022 due to a decline in the total return index and volatility index.
D
Sell 11/30/2021Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to D- from D on 11/30/2021 due to a decline in the growth index, total return index and volatility index.
D
Sell 11/15/2021Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D from E+ on 11/15/2021 due to a noticeable increase in the solvency index, growth index and valuation index. Earnings per share increased from -$0.78 to -$0.0833, operating cash flow increased 29.66% from -$64.16M to -$45.13M, and debt to equity declined from 0.08 to 0.06.
E
Sell 11/8/2021Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to E+ from D- on 11/8/2021 due to a decline in the volatility index and total return index.
D
Sell 9/20/2021Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to D- from D on 9/20/2021 due to a decline in the total return index and volatility index.
D
Sell 9/3/2021Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D from D- on 9/3/2021 due to an increase in the total return index and volatility index.
D
Sell 8/19/2021Downgrade
Clover Health Investments, Corp. (CLOV) was downgraded to D- from D on 8/19/2021 due to a major decline in the efficiency index, solvency index and growth index. Debt to equity increased from 0.09 to 1.54, net income declined 555.99% from -$48.42M to -$317.61M, and earnings per share declined from -$0.1287 to -$0.7779.
D
Sell 5/21/2021Upgraded
Clover Health Investments, Corp. (CLOV) was upgraded to D from D- on 5/21/2021 due to a significant increase in the solvency index, growth index and efficiency index. Total capital increased 2,480.85% from -$27.09M to $644.88M, earnings per share increased from -$2.943 to -$0.1287, and net income increased 61.69% from -$126.39M to -$48.42M.
D
Sell 4/6/2021None
Clover Health Investments, Corp. (CLOV) was downgraded to D- from U on 04/06/2021.
Weiss Ratings